Banner-inner

Press Releases

Press Releases

09/18/2020
Poseida Therapeutics Added to Membership of US Small-Cap Russell 2000® Index
SAN DIEGO , Sept. 18, 2020 /PRNewswire/ --  Poseida Therapeutics, Inc., (Nasdaq: PSTX), a clinical-stage biopharmaceutical company dedicated to utilizing its proprietary gene engineering platform technologies to create next generation cell and gene therapeutics with the capacity to cure, today
07/16/2020
Poseida Therapeutics Appoints Harry J. Leonhardt, Esq. as General Counsel
SAN DIEGO , July 16, 2020 /PRNewswire/ --   Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company dedicated to utilizing proprietary gene engineering platform technologies to create next generation cell and gene therapeutics with the capacity to cure, today announced
07/09/2020
Poseida Therapeutics Announces Pricing of Initial Public Offering
SAN DIEGO, July 9, 2020 /PRNewswire/ -- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to utilizing proprietary gene engineering platform technologies to create next generation cell and gene therapeutics with the capacity to cure, today announced the pricing of its
06/25/2020
Poseida Therapeutics Raises $110 Million in Series D Financing
SAN DIEGO, June 25, 2020 /PRNewswire/ -- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to utilizing proprietary gene engineering platform technologies to create next generation cell and gene therapeutics with the capacity to cure, today announced the closing of a